U.S. Stocks To Watch: FedEx, Costco, Credit Suisse And More

Benzinga2022-09-23

With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:

  • Wall Street expects InMed Pharmaceuticals Inc to report a quarterly loss at $5.50 per share on revenue of $750.00 thousand before the opening bell. InMed Pharmaceuticals shares rose 1.2% to $7.00 in after-hours trading.
  • Costco Wholesale Corporation reported better-than-expected results for its fiscal fourth quarter on Thursday. Costco shares, however, fell 3.3% to $471.02 in the pre-market trading session.
  • EDAP TMS S.A. reported a public offering of American Depositary Shares. However, no size of the offering was disclosed. EDAP shares dropped 5.8% to $8.07 in after-hours trading.
  • FedEx Corporation said its adjusted earnings per share dropped to $3.44 for the quarter ended Aug 31 compared to $4.37 in the year-ago period, while revenue increased to $23.2 billion from $22 billion. FedEx also announced plans to repurchase $1.5 billion of its common stock during fiscal 2023. The company said it plans to repurchase $1 billion of its common stock in the second quarter. FedEx shares slipped 1% to $153.00 in the pre-market trading session.
  • Credit Suisse Group AG shares slumped to a record low after the bank was forced to deny a Reuters report that it is considering exiting the US market, signaling that doubts still remain over the troubled lender’s upcoming strategy revamp. Credit Suisse shares fell 4.67% to $4.49 in premarket trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
18